PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience

In recent years, the preferentially expressed antigen in melanoma (PRAME) has also been used in the histopathological diagnosis of melanocytic lesions, in order to understand if it could constitute a valid, inexpensive, and useful resource in dermatopathological fields. We performed a double-center...

Full description

Bibliographic Details
Main Authors: Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Vincenzo Belsito, Lucia Lospalluti, Caterina Foti, Francesca Arezzo, Miriam Dellino, Nadia Casatta, Carmelo Lupo, Luigi Buongiorno, Alessandra Stellacci, Maricla Marrone, Giuseppe Ingravallo, Eugenio Maiorano, Leonardo Resta
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/9/2197